Glass bottle anti-mechanical impact testing machine - recommended
Time of Update: 2022-09-21
01 N·m Machine size 420mm×330×500mm (length, width and height) Weight 28Kg Working temperature 15°C-50°C Relative humidity 80%, non-condensing working power supply 220V 50Hz glass bottle mechanical impact testing machine - recommendedGlass bottle anti-mechanical impact test machine - recommended "glass bottle jar anti-mechanical impact test method (GB 6552-1986)" is the GB 6552-86 standard, this standard was issued by the National Bureau of Standards in 1986-06-21, and began to be implemented in 1987-03-01.
Pharmaceutical equipment welcomes a big plus and will open a new journey for the industry
Time of Update: 2022-06-14
After years of development, my country's pharmaceutical equipment products are becoming increasingly diverse, with continuous specifications, and the market size is showing an increasing trend, which has basically been able to meet the production needs of domestic pharmaceutical companies.
What is the potential of NAMPT, a target in the tumor field
Time of Update: 2022-05-16
Intracellular NAMPT is mainly distributed in the cytoplasm, nucleus and mitochondria, uses ATP as an activator, plays its biological function as a rate-limiting enzyme in the NAD salvage synthesis pathway, and participates in energy metabolism, reductive biosynthesis, antioxidant reactions, cellular live and die .
More than 240 pharmaceutical companies have disclosed performance forecasts, with dazzling net profits concentrated in the fields of vaccines and testing
Time of Update: 2022-05-02
. In addition to Zhifei Bio and CanSino, the net profit of vaccine companies such as Olin Bio and Kangtai Bio is also expected to increase significantly year-on-year in 2021.
Advancing the research and development of pet drugs, looking forward to Kangchen Pharmaceutical to create a Chinese version of the Pfizer model
Time of Update: 2022-03-07
This article will interpret the significance of domestic pharmaceutical companies advancing pet drug research and development from the perspectives of strategic value and market space .
The US claims that Biden signed sanctions against entities and individuals in 4 countries, including 4 Chinese pharmaceutical companies and 1 individual
Time of Update: 2022-01-11
S. Department of the Treasury website, the U.
S. 's so-called sanctions are based on combating drug abuse and addiction problems such as fentanyl, and it is accused of these companies and individuals "participating in the global illegal drug trade .
In the future, medical representatives will continue to be under pressure, where is the way out
Time of Update: 2022-01-08
So, in the context of the continuous deepening of medical reform and the normalization of centralized procurement, how should these medical representatives find new ways in the future?
Opportunities in these fields have come after the collection
Time of Update: 2021-12-07
The trend of low-level competition will be terminated, which is also in line with the global development trend of the pharmaceutical industry-gradually concentrated, and small and medium-sized enterprises without innovative capabilities will be eliminated .
The US version of "medical insurance catalog negotiation" is here
Time of Update: 2021-09-19
"The NHS supports the passage of legislation and allows the federal government to negotiate annually to reduce the prices of the most expensive prescription drugs and pass the costs on to private insurance companies .
5 billion new dosage forms of antihypertensive drugs, this pharmaceutical company will win
Time of Update: 2021-09-12
According to data from Mi Nei. com, in 2020, the total sales of valsartan in Chinese urban public hospitals , county-level public hospitals, urban community centers, township health centers (referred to as Chinese public medical institutions) and the terminal valsartan in Chinese urban physical pharmacies will exceed 5 billion yuan.
From Zebutinib to Obstinib, BeiGene and Nuocheng Jianhua's global commercialization prospects
Time of Update: 2021-08-14
Recently, BeiGene announced that the interim analysis of a global Phase III SEQUOIA trial of its BTK inhibitor Zebutinib has achieved positive main results, and the study has reached its primary endpoint .
Tianyao: Salmeterol xinafoate API passed CDE technical review
Time of Update: 2021-07-19
On March 11, Tianyao shares announced that recently, the company's salmeterol xinafoate API passed the technical review of the Drug Evaluation Center of the National Medical Products Administration, and the registration information of the CDE API, pharmaceutical excipients and pharmaceutical packaging materials was announced The registration status indicator displayed on the platform changes to "A" .
Online prescription drugs are coming, but Tai'antang sold this well-known medical e-commerce company
Time of Update: 2021-07-08
After the transaction is completed, the listed company will divest its original pharmaceutical e-commerce business, and focus its resources on the main businesses such as the research and development, manufacturing and sales of Chinese patent medicines, and the initial processing and sales of Chinese medicinal materials .
Howson Pharmaceuticals explores the innovative way of precise diagnosis and treatment of lung cancer
Time of Update: 2021-07-06
Academician Yu Jinming of the Chinese Academy of Engineering and Professor Wu Yilong of Guangdong Provincial People’s Hospital as the chairperson of the conference, and many participating experts focused on the exploration and innovation of lung cancer diagnosis and treatment, and once again "liked" Amelox® (ametinib mesylate), calling it The patient brings new hope of life .
The Petroleum and Chemical Industry Index is red again
Time of Update: 2021-06-17
com last week, the Shanghai Composite Index fell 0.
89%, and the petroleum sector index rose by 0.
Last week, the top five listed companies on the Shanghai and Shenzhen stock exchanges were Dazhi Technology up 34.